Cargando…
Perspectives on Nanodelivery to the Brain: Prerequisites for Successful Brain Treatment
[Image: see text] Nanocarriers (NCs) are promising tools to improve drug delivery across the blood–brain barrier (BBB) for more effective treatment of brain disorders, although there is a scarcity of clinical translation of brain-directed NCs. In order to drive the development of brain-oriented NCs...
Autores principales: | Hu, Yang, Hammarlund-Udenaes, Margareta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610229/ https://www.ncbi.nlm.nih.gov/pubmed/33064009 http://dx.doi.org/10.1021/acs.molpharmaceut.0c00881 |
Ejemplares similares
-
The brain slice method for studying drug distribution in the CNS
por: Loryan, Irena, et al.
Publicado: (2013) -
On The Rate and Extent of Drug Delivery to the Brain
por: Hammarlund-Udenaes, Margareta, et al.
Publicado: (2007) -
Understanding the Blood‐Brain Barrier and Beyond: Challenges and Opportunities for Novel CNS Therapeutics
por: de Lange, Elizabeth C. M., et al.
Publicado: (2022) -
Improved method for quantitative analysis of the cyclotide kalata B1 in plasma and brain homogenate
por: Melander, Erik, et al.
Publicado: (2016) -
Heterogeneous drug tissue binding in brain regions of rats, Alzheimer’s patients and controls: impact on translational drug development
por: Gustafsson, Sofia, et al.
Publicado: (2019)